<?xml version="1.0" encoding="UTF-8"?>
<p id="par0055">
 <bold>Chung:</bold> Many people are curious about how clinical data, including effectiveness and safety data, of KM treatment provided at the COVID-19 teleconsultation centers are being collected. Some argue that we need to accumulate decent results to participate in notable future plans. What is your take on this?
</p>
